NCT03654664 - To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine | Biotech Hunter

Enrollment

119

Participants

Timeline

Start Date

June 20, 2017

Primary Completion Date

June 24, 2019

Study Completion Date

June 24, 2019

Conditions

Hepatitis A Vaccine

Interventions

BIOLOGICAL

Inactivated hepatitis A vaccine

Inactivated hepatitis A virus antigen 250 U (Name of viral strain: TZ84)

BIOLOGICAL

Havrix Inj

720 ELISA/0.5 mL Junior (Inactivated hepatitis A virus antigen 160 U (Name of viral strain: HM175 Inj)

Trial Locations (10)

Korea University Ansan Hospital, Ansan

Chanwon Fatima Hospital, Changwon

The Catholic University of Korea, Incheon St.Mary's Hospital, Incheon

The Catholic University of Korea, St.Vincent's Hospital., Suwon

KeiMyung University Dongsan Medical Center, Daegu

Gachon University Gil Hospital, Incheon

Wonju Sevrance Christian Hospital, Wŏnju

Hanil General Hospital, Seoul

Korea cancer center Hospital, Seoul

Nowon Eulji Medical center , Eulji University, Seoul